Serum 5-s-cysteinyldopa for identifying non-responders to nivolumab treatment of melanoma.

e21068Background: Despite considerable advances in the treatment of metastatic melanoma, reliable markers to monitor treatment response are still lacking. 5-S-cysteinyldopa (5-S-CD) is a precursor ...